Article Data

  • Views 196
  • Dowloads 57

Original Research

Open Access

Diagnostic re-evaluation of non-odontogenic orofacial pain after treatment failure: a retrospective case series

  • Hao Chih Chuang1,*,
  • Hisashi Sato1
  • Kosei Kubota2
  • Wataru Kobayashi2

1Department of Dentistry and Oral Surgery, Tsugaru General Hospital, 037-0074 Aomori, Japan

2Department of Oral and Maxillofacial Surgery, Hirosaki University Graduate School of Medicine, 036-8563 Aomori, Japan

DOI: 10.22514/jofph.2026.039 Vol.40,Issue 3,May 2026 pp.93-104

Submitted: 25 November 2025 Accepted: 29 January 2026

Published: 12 May 2026

*Corresponding Author(s): Hao Chih Chuang E-mail: b210097038@gmail.com

Abstract

Background: Orofacial pain often arises from overlapping odontogenic and non-odontogenic causes, which can lead to misdiagnosis and unnecessary irreversible procedures. Practical guidance on diagnostic re-evaluation in treatment-refractory cases with negative dental findings remain limited. Methods: This retrospective case series describes six illustrative patients (one man and five women; median age, 74.5 years) selected from referrals for suspected non-odontogenic orofacial pain, based on diagnostic difficulty, treatment refractoriness, and objective negative dental findings. Two oral and maxillofacial surgeons independently re-evaluated each case using the International Classification of Orofacial Pain, the 3rd edition of the International Classification of Headache Disorders, and the Diagnostic Criteria for Temporomandibular Disorders. Results: The final or most strongly suspected diagnoses included persistent idiopathic dentoalveolar pain, lingual nerve injury, trigeminal neuralgia, trigeminal autonomic cephalalgia, and myofascial pain. The median diagnostic delay was 17 months (interquartile range, 7–96). Initial empiric dental management (e.g., antibiotics and/or nonsteroidal anti-inflammatory drugs (NSAIDs)) was insufficient in all cases. Pain intensity improved from a median numerical rating scale score of 8 at baseline to 0–2 at final observation. Across cases, common diagnostic pitfalls included premature attribution to a single cause, overreliance on imaging or prior medication history, and insufficient musculoskeletal or neurological examination. One or more clinical features prompting diagnostic re-evaluation were observed in each case, including persistent pain with objective negative dental findings, autonomic signs, or incongruent treatment response. Conclusions: In cases of treatment-refractory orofacial pain with objective negative dental findings, suspending further irreversible interventions and conducting systematic diagnostic re-evaluation may help reduce diagnostic delays and avoid unnecessary procedures.


Keywords

Orofacial pain; Persistent dentoalveolar pain disorder; Trigeminal neuralgia; Differential diagnosis; Non-odontogenic pain


Cite and Share

Hao Chih Chuang,Hisashi Sato,Kosei Kubota,Wataru Kobayashi. Diagnostic re-evaluation of non-odontogenic orofacial pain after treatment failure: a retrospective case series. Journal of Oral & Facial Pain and Headache. 2026. 40(3);93-104.

References

[1] Chala S, Moldoveanu A, Špiljak B, Blanco RBR, Ünsal RBK, Sivaramkrishnan G, et al. Global burden of orofacial pain in adults in low- and middle-income countries: a systematic review and meta-analysis. National Journal of Maxillofacial Surgery. 2025; 16: 401–406.

[2] International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020; 40: 129–221.

[3] Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018; 38: 1–211.

[4] Kang Y, Fu Y, Jian K, Liu J, Shao L. Decoding orofacial pain: a translational review of mechanisms and novel therapies. The Journal of Headache and Pain. 2025; 26: 252.

[5] Ando A, Han PP, Patel S. Thinking outside the tooth: diagnosis and management of patients with neuropathic orofacial pain. Dental Clinics of North America. 2022; 66: 229–244.

[6] Keith DA, Kulich RJ, Schatman ME, Scrivani SJ. Orofacial pain case histories with literature reviews. Dental Clinics of North America. 2023; 67: xiii–xvi.

[7] De Laat A. Differential diagnosis of toothache to prevent erroneous and unnecessary dental treatment. Journal of Oral Rehabilitation. 2020; 47: 775–781.

[8] Bae SH, Shim GJ, Kwon TG. Diagnosis and management of persistent idiopathic facial pain following dental procedures: a retrospective study. Journal of the Korean Association of Oral and Maxillofacial Surgeons. 2025; 51: 269–277.

[9] Chun JY, Shim YJ. Analysis of final diagnosis of patients with suspected nonodontogenic toothache: a retrospective study. Journal of Oral Medicine and Pain. 2024; 49: 57–64.

[10] Hassan AF, Al Sheakh A, Badran SA, Mahmood AA, Alhamdani FY. Misdiagnosis-driven dental extractions in patients with trigeminal neuralgia: a retrospective study. Journal of Multidisciplinary Healthcare. 2025; 18: 1999–2005.

[11] Vally ZI, Khammissa RAG, Feller G, Ballyram R, Beetge M, Feller L. Errors in clinical diagnosis: a narrative review. Journal of International Medical Research. 2023; 51: 3000605231162798.

[12] Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. Journal of Oral & Facial Pain and Headache. 2014; 28: 6–27.

[13] Guan G, Polonowita AK, Mei L, Polonowita DA, Polonowita AJ. Chronic orofacial pain and pharmacological management: a clinical guide. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. 2025; 140: e1–e21.

[14] Statistics Bureau of Japan (Ministry of Internal Affairs and Communications). Population estimates (as of 01 October 2024). 2024. Available at: https://www.stat.go.jp/english/data/jinsui/2024np/index.html (Accessed: 20 December 2025).

[15] Heir GM, Ananthan S, Kalladka M, Kuchukulla M, Renton T. Persistent idiopathic dentoalveolar pain: is it a central pain disorder? Dental Clinics of North America. 2023; 67: 71–83.

[16] May A, Benoliel R, Imamura Y, Pigg M, Baad-Hansen L, Svensson P, et al. Orofacial pain for clinicians: a review of constant and attack-like facial pain syndromes. Cephalalgia. 2023; 43: 3331024231187160.

[17] Croskerry P. Cognitive forcing strategies in clinical decision making. Annals of Emergency Medicine. 2003; 41: 110–120.

[18] Graber ML. Educational strategies to reduce diagnostic error: can you teach this stuff? Advances in Health Sciences Education: Theory and Practice. 2009; 14: 63–69.

[19] Sanner F, Sonntag D, Hambrock N, Zehnder M. Patients with persistent idiopathic dentoalveolar pain in dental practice. International Endodontic Journal. 2022; 55: 231–239.

[20] Herrero Babiloni A, Nixdorf DR, Moana-Filho EJ. Persistent dentoalveolar pain disorder: a putative intraoral chronic overlapping pain condition. Oral Diseases. 2020; 26: 1601–1609.

[21] Van der Cruyssen F, Willaert R, Miloro M. Lingual nerve injuries: recognized complications or preventable errors? Frontiers in Oral Health. 2025; 6: 1608292.

[22] Selvi F, Yildirimyan N, Zuniga JR. Inferior alveolar and lingual nerve injuries: an overview of diagnosis and management. Frontiers of Oral and Maxillofacial Medicine. 2022; 4: 27.

[23] Van der Cruyssen F, Palla B, Jacobs R, Politis C, Zuniga J, Renton T. Consensus guidelines on training, diagnosis, treatment and follow-up care of trigeminal nerve injuries. International Journal of Oral and Maxillofacial Surgery. 2024; 53: 68–77.

[24] Kouri M, Rekatsina M, Vadalouca A, Viswanath O, Varrassi G. Oral neuropathy associated with commonly used chemotherapeutic agents: a narrative review. Current Pain and Headache Reports. 2024; 28: 1209–1217.

[25] Ruggiero SL, Dodson TB, Aghaloo TL, Carlson ER, Ward BB, Kademani D, et al. American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws—2022 update. Journal of Oral and Maxillofacial Surgery. 2022; 80: 920–943.

[26] International Headache Society. The International Classification of Headache Disorders, 3rd edition (ICHD-3): 13.1 Trigeminal neuralgia. 2025. Available at: https://ichd-3.org/13-painful-cranial-neuropathies-and-other-facial-pains/13-1-trigeminal-neuralgia/ (Accessed: 10 October 2025).

[27] Latorre G, González-García N, García-Ull J, González-Oria C, Porta-Etessam J, Molina FJ, et al. Diagnosis and treatment of trigeminal neuralgia: consensus statement from the Spanish Society of Neurology’s Headache Study Group. Neurologia. 2023; 38: S37–S52.

[28] Botros J, Nixdorf DR. Orofacial trigeminal autonomic cephalalgias: a review of case reports. CRANIO®. 2026; 44: 453–460.

[29] Fernández-de-Las-Peñas C, Nijs J, Cagnie B, Gerwin RD, Plaza-Manzano G, Valera-Calero JA, et al. Myofascial pain syndrome: a nociceptive condition comorbid with neuropathic or nociplastic pain. Life. 2023; 13: 694.

[30] Busse JW, Casassus R, Carrasco-Labra A, Durham J, Mock D, Zakrzewska JM, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. The BMJ. 2023; 383: e076227.

[31] Dinsdale A, Forbes R, Thomas L, Treleaven J. The management experiences, needs and preferences of individuals seeking care for persistent intra-articular temporomandibular disorders: a qualitative study. Journal of Oral Rehabilitation. 2022; 49: 10–21.

[32] Groopman JE. How doctors think. Houghton Mifflin Harcourt: Boston, MA, USA. 2008.


Submission Turnaround Time

Top